Company intelligence / Profile preview

TRIZ Biopharma Innovation

Edison, New Jersey, USAtrizbiopharma.com ↗
Ownership
Private
Development stage
Other
01

Overview

TRIZ Biopharma Innovation has developed a proprietary drug discovery platform based on the principles of dynamic self-adapting chemical structures. Their approach enables the creation of "dynamic drugs"—therapeutics that adapt their structure in response to patient-specific biological environments. The company reports successful application of its technology in veterinary antivirals and battlefield hemostatic powders ("Gemma"), with ongoing research into oncology, anti-infectives, neurodegenerative diseases, cardiovascular/metabolic disorders, diagnostics devices/implants. No published human clinical trial results are available as of June 2025

Therapeutic areas
NeurologyInfectious DiseasesEndocrinologyOncologyCardiovascular
Modalities
Small moleculeAntisense oligonucleotidePeptidesNanoparticle (supramolecular nanostructures)
Industry
Biotech
02

Drug pipeline

5 assets

FRNA-211

Preclinical

4 more assets in the full pipeline.

Request access →
03

Partnerships

Not publicly disclosed as major pharma partnerships.

Beyond the preview

Go deeper on TRIZ Biopharma Innovation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TRIZ Biopharma Innovation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call